Immuneoncia Therapeutics Inc

424870

Company Profile

  • Business description

    Immuneoncia Therapeutics Inc is an immuno-oncology-centric biopharmaceutical company. The company focuses on developing immunotherapies for cancer treatment.

  • Contact

    25, Tapsil-ro 35beon-gil
    Giheung-gu, Yongin-si
    Gyeonggi-do17084
    KOR

    T: +82 262835096

    http://www.immuneoncia.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

Stocks News & Analysis

stocks

Unconventional wisdom: Are dividends the answers?

As investors toil in complexity the obvious solution may be the right one.
stocks

Netflix: A business that’s nearly flawless

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks

Trump’s US dollar assault is fuelling CBA’s rise

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,934.1045.30-0.50%
CAC 407,818.2832.15-0.41%
DAX 4024,295.9355.110.23%
Dow JONES (US)44,693.91316.38-0.70%
FTSE 1009,138.3776.880.85%
HKSE25,667.18129.110.51%
NASDAQ21,057.9637.940.18%
Nikkei 22541,701.94124.40-0.30%
NZX 50 Index12,829.6624.530.19%
S&P 5006,363.354.440.07%
S&P/ASX 2008,664.2045.20-0.52%
SSE Composite Index3,604.681.05-0.03%

Market Movers